melatonin has been researched along with Lymph Node Metastasis in 9 studies
Excerpt | Relevance | Reference |
---|---|---|
"Several experimental studies have shown that melatonin has an oncostatic action, either by stimulating host antitumor immune defenses or by directly inhibiting the growth of some cancer histotypes, including melanoma." | 9.08 | Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma. ( Barni, S; Brivio, F; Brivio, O; Crippa, D; Lissoni, P; Meregalli, S; Tancini, G, 1996) |
"Circadian rhythm of 6-sulphatoxymelatonin (aMT6s) excretion has been studied in stomach cancer (n = 89) and colorectal cancer (n = 86) patients." | 7.78 | [Age-related changes of 6-sulphatoxymelatonin excretion in stomach and colorectal cancer patients]. ( Anisimov, VN; Arutiunian, AV; Ermachenkov, MN; Guliaev, AV; Miliutina, IuP, 2012) |
"Between 1994 and 1995, 1 day nocturnal infusion of 5-fluorouracil (5-FU) was performed prior to surgery in 13 primary breast cancer patients; 300 mg/m2 of 5-FU was infused constantly from 2100 h to 0700 h via peripheral vein with a volumetric pump." | 7.69 | Nocturnal 5-fluorouracil infusion to patients with breast cancer prior to surgery: appearance of 5-fluorouracil-induced AgNORs aggregation (FAA). ( Furuya, Y; Kohno, N; Saitoh, Y; Yamamoto, K; Yamamoto, M, 1997) |
"A seasonal variation in the month of initial detection of breast cancer has been previously observed in pre-menopausal women, and it has been proposed that this may be due to cyclic changes in tumour growth mediated by the effects of melatonin on ovarian function." | 7.68 | Seasonal changes in serum melatonin in women with previous breast cancer. ( Gibbs, EE; Holdaway, IM; Hopkins, KD; Mason, BH; Rajasoorya, C, 1991) |
"Melatonin is a hormone synthesized by the pineal gland at night in the absence of light." | 5.48 | Evaluation of melatonin and AFMK levels in women with breast cancer. ( Bordin-Junior, NA; de Almeida, EA; de Campos Zuccari, DAP; de Castro, TB, 2018) |
"Several experimental studies have shown that melatonin has an oncostatic action, either by stimulating host antitumor immune defenses or by directly inhibiting the growth of some cancer histotypes, including melanoma." | 5.08 | Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma. ( Barni, S; Brivio, F; Brivio, O; Crippa, D; Lissoni, P; Meregalli, S; Tancini, G, 1996) |
" Recent studies indicate that pineal hormone melatonin by its receptor melatonin 1 (MT1) also influences the development and growth of breast cancer cells." | 3.96 | Role of Melatonin in Breast Carcinoma: Correlation of Expression Patterns of Melatonin-1 Receptor With Estrogen, Progesterone, and HER2 Receptors. ( Bal, A; Goyal, R; Gupta, T; Sahni, D; Singh, G, 2020) |
"Circadian rhythm of 6-sulphatoxymelatonin (aMT6s) excretion has been studied in stomach cancer (n = 89) and colorectal cancer (n = 86) patients." | 3.78 | [Age-related changes of 6-sulphatoxymelatonin excretion in stomach and colorectal cancer patients]. ( Anisimov, VN; Arutiunian, AV; Ermachenkov, MN; Guliaev, AV; Miliutina, IuP, 2012) |
"Between 1994 and 1995, 1 day nocturnal infusion of 5-fluorouracil (5-FU) was performed prior to surgery in 13 primary breast cancer patients; 300 mg/m2 of 5-FU was infused constantly from 2100 h to 0700 h via peripheral vein with a volumetric pump." | 3.69 | Nocturnal 5-fluorouracil infusion to patients with breast cancer prior to surgery: appearance of 5-fluorouracil-induced AgNORs aggregation (FAA). ( Furuya, Y; Kohno, N; Saitoh, Y; Yamamoto, K; Yamamoto, M, 1997) |
"A seasonal variation in the month of initial detection of breast cancer has been previously observed in pre-menopausal women, and it has been proposed that this may be due to cyclic changes in tumour growth mediated by the effects of melatonin on ovarian function." | 3.68 | Seasonal changes in serum melatonin in women with previous breast cancer. ( Gibbs, EE; Holdaway, IM; Hopkins, KD; Mason, BH; Rajasoorya, C, 1991) |
"Melatonin receptors can inhibit breast and prostate cancers; however, little is known regarding their effects on oral squamous cell carcinoma." | 1.72 | Effects of melatonin receptor expression on prognosis and survival in oral squamous cell carcinoma patients. ( Hwang, DS; Jang, MA; Kim, GC; Kim, UK; Park, HK; Ryu, MH, 2022) |
"Melatonin is a hormone synthesized by the pineal gland at night in the absence of light." | 1.48 | Evaluation of melatonin and AFMK levels in women with breast cancer. ( Bordin-Junior, NA; de Almeida, EA; de Campos Zuccari, DAP; de Castro, TB, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Park, HK | 1 |
Ryu, MH | 1 |
Hwang, DS | 1 |
Kim, GC | 1 |
Jang, MA | 1 |
Kim, UK | 1 |
Fan, L | 1 |
Xiong, YP | 1 |
Liu, HT | 1 |
Min, X | 1 |
Tang, YQ | 1 |
Zhang, ZY | 1 |
de Castro, TB | 1 |
Bordin-Junior, NA | 1 |
de Almeida, EA | 1 |
de Campos Zuccari, DAP | 1 |
Goyal, R | 1 |
Gupta, T | 1 |
Bal, A | 1 |
Sahni, D | 1 |
Singh, G | 1 |
Ermachenkov, MN | 1 |
Guliaev, AV | 1 |
Arutiunian, AV | 1 |
Miliutina, IuP | 1 |
Anisimov, VN | 1 |
Lissoni, P | 2 |
Brivio, O | 1 |
Brivio, F | 1 |
Barni, S | 2 |
Tancini, G | 2 |
Crippa, D | 1 |
Meregalli, S | 1 |
Cazzaniga, M | 1 |
Scardino, E | 1 |
Musci, R | 1 |
Maffezzini, M | 1 |
Meroni, T | 1 |
Rocco, F | 1 |
Conti, A | 1 |
Maestroni, G | 1 |
Furuya, Y | 1 |
Yamamoto, K | 1 |
Kohno, N | 1 |
Yamamoto, M | 1 |
Saitoh, Y | 1 |
Holdaway, IM | 1 |
Mason, BH | 1 |
Gibbs, EE | 1 |
Rajasoorya, C | 1 |
Hopkins, KD | 1 |
1 trial available for melatonin and Lymph Node Metastasis
Article | Year |
---|---|
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Follow-Up Stu | 1996 |
8 other studies available for melatonin and Lymph Node Metastasis
Article | Year |
---|---|
Effects of melatonin receptor expression on prognosis and survival in oral squamous cell carcinoma patients.
Topics: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymphatic Metastas | 2022 |
[Evaluation of the role of melatonin in the metastasis of papillary thyroid carcinoma].
Topics: Adult; Carcinoma, Papillary; Humans; Lymphatic Metastasis; Melatonin; Thyroid Cancer, Papillary; Thy | 2019 |
Evaluation of melatonin and AFMK levels in women with breast cancer.
Topics: Biomarkers; Breast Neoplasms; Circadian Rhythm; Female; Humans; Kynuramine; Lymphatic Metastasis; Me | 2018 |
Role of Melatonin in Breast Carcinoma: Correlation of Expression Patterns of Melatonin-1 Receptor With Estrogen, Progesterone, and HER2 Receptors.
Topics: Adult; Blood Vessels; Breast Neoplasms; Correlation of Data; Cross-Sectional Studies; Epithelial Cel | 2020 |
[Age-related changes of 6-sulphatoxymelatonin excretion in stomach and colorectal cancer patients].
Topics: Adult; Age Factors; Aged; Chronobiology Disorders; Circadian Rhythm; Colorectal Neoplasms; Female; H | 2012 |
Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combi | 1997 |
Nocturnal 5-fluorouracil infusion to patients with breast cancer prior to surgery: appearance of 5-fluorouracil-induced AgNORs aggregation (FAA).
Topics: Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Lymphatic Metastasis; | 1997 |
Seasonal changes in serum melatonin in women with previous breast cancer.
Topics: Adult; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Melatonin; Menstruation; Periodicity; | 1991 |